Rare Oslo bio IPO blows out on day one
The Oslo Stock Exchange is set to host a rare biotech IPO. Nordic Nanovector, a Norwegian company that is developing antibody-radio conjugates, is seeking to raise Nkr400m ($50m) of new capital.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: